The regulatory role of DPP4 in atherosclerotic disease
Abstract The increasing prevalence of atherosclerosis has become a worldwide health concern. Although significant progress has been made in the understanding of atherosclerosis pathogenesis, the underlying mechanisms are not fully understood. Recent studies suggest dipeptidyl peptidase-4 (DPP4), a r...
Main Authors: | Lihua Duan, Xiaoquan Rao, Chang Xia, Sanjay Rajagopalan, Jixin Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-017-0558-y |
Similar Items
-
Acute pancreatitis with gliptins: Is it a clinical reality?
by: Muthukrishnan Jayaraman, et al.
Published: (2013-01-01) -
Choosing a Gliptin
by: Vishal Gupta, et al.
Published: (2011-01-01) -
Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid
by: Ágnes Kinyó, et al.
Published: (2021-04-01) -
DPP4 in Diabetes
by: Diana eRöhrborn, et al.
Published: (2015-07-01) -
Clinical Use of DPP-4 Inhibitors
by: Baptist Gallwitz
Published: (2019-06-01)